 Vertex Pharma beat third-quarter expectations Thursday and raised its sales outlook, helping VRTX stock shrug off some regular session pain. The post Vertex Pharmaceuticals Jumps After Quarterly Beat, Raises 2022 Outlook appeared first on Investors Business Daily. 